Interested in responsible gene editing? Join the (new) club
By Martin Enserink,
Science
| 03. 27. 2018
A group of European scientists has founded an international association to discuss and provide guidance on the ethical use of genome editing, a technique with the potential to transform everything from food production and human health to science itself. Organizers launched the new Association for Responsible Research and Innovation in Genome Editing (ARRIGE) at a kick-off meeting in Paris this past Friday.
The high hopes and fears around gene editing—which has the potential to lead to new crops and the elimination of diseases, but also to “designer babies” or insects running amok—have been the topic of dozens of meetings and reports, including a high-profile “summit” in Washington, D.C., in 2015. National science academies and councils, the Council of Europe, and several professional societies have weighed in.
But some researchers worry that the debate isn’t broad enough, or lacks the kind of dialogue needed to reach a societal consensus on the introduction of such a pathbreaking new technology. At the Washington, D.C., summit, for instance, “discussion split into two camps: scientific experts explored technical issues, whereas scholars who...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...